Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-01-28 Vasista Vittal Grant or award · Stock Option (Right to Buy) +75,000 75,000
2016-01-28 Mills Kenneth T. President and CEO Grant or award · Stock Option (Right to Buy) +225,000 225,000
2016-01-28 Simpson Curran Grant or award · Stock Option (Right to Buy) +10,000 10,000
2015-10-14 STUMP DAVID C Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2015-09-22 Flynn James E 10% owner Conversion +771,963 771,963
2015-09-22 Flynn James E 10% owner Conversion +397,079 1,169,042
2015-09-22 Flynn James E 10% owner Purchase +87,500 $22.00 $1.9M 1,256,542
2015-09-22 Flynn James E 10% owner Purchase +38,500 $22.00 $847K 38,500
2015-09-22 Flynn James E 10% owner Purchase +49,000 $22.00 $1.1M 49,000
2015-09-22 Flynn James E 10% owner Conversion · Series C Convertible Preferred Stock −771,963 0
2015-09-22 Flynn James E 10% owner Conversion · Series D Convertible Preferred Stock −397,079 0
2015-09-22 Vasista Vittal Conversion +15,440 115,440
2015-09-22 Vasista Vittal Conversion · Series C Preferred Stock −15,440 0
2015-09-22 HAYDEN DONALD J JR Director Conversion +38,599 38,599
2015-09-22 HAYDEN DONALD J JR Director Conversion · Series C Preferred Stock −38,599 0
2015-09-22 ENGLEMAN EDGAR Director Conversion +826,341 826,341
2015-09-22 ENGLEMAN EDGAR Director Conversion +114,108 114,108
2015-09-22 ENGLEMAN EDGAR Director Conversion · Series D Preferred Stock −826,341 0
2015-09-22 ENGLEMAN EDGAR Director Conversion · Series D Preferred Stock −114,108 0
2015-09-22 Mills Kenneth T. Director Conversion +15,440 15,440

Page 55 of 56 · 1,104 trades